Short answer
Tonix Pharmaceuticals Holding Corp. (TNXP) filed an 8-K current report with the SEC on July 21, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Chief Medical Officer Gregory M. Sullivan retiring effective August 20, 2026.
Tonix Pharmaceuticals Holding Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Chief Medical Officer Gregory M. Sullivan retiring effective August 20, 2026
- Departure creates leadership transition risk for clinical development and regulatory execution
- No successor or transition arrangements disclosed in the filing section
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tonix Pharmaceuticals Holding Corp. 8-K filings
Get the next TNXP 8-K as it lands
Follow TNXP for push alerts, or ask the research agent what this filing means.